Table 1.
Clinical, laboratory, and demographic characteristics of sarcoidosis patients with (N = 6) and without (N = 36) sacroiliitis.
| Parameter | Patients with sacroiliitis (% of total) | Patients without sacroiliitis (% of total) | P value |
|---|---|---|---|
| Age, mean (year) | 55 | 43.7 | 0.046 |
| Gender (female) | 6 (100%) | 26 (72.2%) | 0.308 |
| Disease duration (month) | 17.8 | 41.3 | 0.800 |
| Inflammatory back pain | 6 (100%) | 8 (22.2%) | 0.001 |
| Enthesitis | 6 (100%) | 6 (16.7%) | 0.000 |
| Erythema nodosum | 5 (83.3%) | 15 (41.7%) | 0.087 |
| Uveitis | 0 (0%) | 3 (8.3%) | 1.000 |
| Ankle arthritis | 6 (66.7%) | 22 (61.1%) | 1.000 |
| Elevated serum ACE level | 2 (33.3%) | 13 (38.9%) | 1.000 |
| Elevated serum calcium level | 2 (33.3%) | 4 (11.1%) | 0.197 |
| Elevated serum D3 level | 0 (0%) | 2 (5.6%) | 1.000 |
| HLAB27 positive | 0 (0%) | 2 (5.6%) | 1.000 |
| Elevated ESR | 3 (50%) | 26 (72.2%) | 0.353 |
| Elevated CRP | 2 (33.3%) | 28 (77.8%) | 0.046 |
ACE: angiotensin converting enzyme; ESR: erythrocyte sedimentation rate; CRP: C reactive protein.